Stockscreener 앱 받기
4.16
5.32%
0.21
시간 외 거래:
4.15
-0.010
-0.24%
전일 마감가:
$3.95
열려 있는:
$3.96
하루 거래량:
82,563
Relative Volume:
1.17
시가총액:
$4.50M
수익:
-
순이익/손실:
$-7.29M
주가수익비율:
-0.1707
EPS:
-24.3686
순현금흐름:
$-6.81M
1주 성능:
-27.40%
1개월 성능:
+11.83%
6개월 성능:
+19.88%
1년 성능:
+4.00%
1일 변동 폭
$3.8581
$4.27
1주일 범위
$3.59
$5.72
52주 변동 폭
$2.36
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
명칭
Heartsciences Inc
전화
682-237-7781
주소
550 RESERVE ST, SUITE 360, SOUTHLAKE
HSCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
4.16 | 6.19M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
120.51 | 232.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.65 | 153.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.90 | 150.87B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.53 | 114.55B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.18 | 46.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Heartsciences Inc 주식(HSCS)의 최신 뉴스
What makes HeartSciences Inc. stock attractive to long term investorsSmart Money Signals - Newser
What makes HeartSciences Inc. stock price move sharplyFree Best Performing Stock Alerts - beatles.ru
How HeartSciences Inc. Equity Warrant stock performs during market volatilityFree Smart Money Group - Newser
Why Spire Global Inc. stock attracts strong analyst attentionSecure Growth Trading Plan - Newser
Why HeartSciences Inc. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - Newser
why heartsciences inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
What makes Giftify Inc. stock price move sharplyFree Stock Movement Tracking - Newser
Why Roku Inc. stock attracts strong analyst attentionFree Join Group - Newser
Why HeartSciences Inc. Equity Warrant stock attracts strong analyst attentionStrong Return Daily Alerts - Newser
What makes HeartSciences Inc. Equity Warrant stock price move sharplyRisk Limited High Gain Trades - Newser
Why First Mid Bancshares Inc. stock attracts strong analyst attentionFree Stock Tips Group - Newser
HeartSciences board approves equity plan amendment and reports capital updates - Investing.com India
HeartSciences board approves equity plan amendment and reports capital updates By Investing.com - Investing.com South Africa
Ichnos Glenmark Innovation and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody - Investing News Network
AbbVie and Ichnos Glenmark Innovation Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody - Investing News Network
HeartSciences amends bylaws to add jury trial waiver and ownership threshold - Investing.com India
Heart Test Laboratories Updates Bylaws to Align with Texas Law - TipRanks
AbbVie Declares Quarterly Dividend - Investing News Network
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm - Diagnostic and Interventional Cardiology
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network
HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm - MSN
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Al - GuruFocus
Heart Test Laboratories Receives FDA Breakthrough Designation - TipRanks
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Algorithm | HSCS Stock News - GuruFocus
Revolutionary AI Algorithm Detects Silent Killer Heart Disease 2 Years Earlier, FDA Fast-Tracks Approval - Stock Titan
Heart Test Laboratories Files Certificate for Preferred Stock - TipRanks
HeartSciences announces grant by USPTO for ECG assessment of heart function - TipRanks
HeartSciences Inc. Announces the Grant by the United States Patent and Trademark Office of A foundational Patent Covering the Establishing the Estimation of Echocardiography parameters Indicative of Heart Function Using an ECG - marketscreener.com
Heart Test Laboratories Secures Foundational Patent for AI-ECG - TipRanks
HeartSciences (HSCS) Strengthens IP Portfolio with New Patent Grant | HSCS Stock News - GuruFocus
HeartSciences Inc. Secures Foundational Patent for AI-Driven ECG Technology Enhancing Heart Function Detection - Nasdaq
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - The Manila Times
Revolutionary AI Patent: HeartSciences Transforms ECG Technology for Earlier Heart Disease Detection - Stock Titan
HeartSciences signs first MyoVista Insights platform customer - Yahoo Finance
HeartSciences Inc. Signs First MyVista Insights Platform Customer - marketscreener.com
HeartSciences Signs First MyoVista Insights(TM) Platform Customer - marketscreener.com
HeartSciences (HSCS) Secures First Client for MyoVista Insights in the UK | HSCS Stock News - GuruFocus
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewswire
HeartSciences amends corporate articles By Investing.com - Investing.com Canada
HeartSciences amends corporate articles - Investing.com
Heart Test Laboratories Announces $15M Securities Offering - TipRanks
Heartsciences Inc (HSCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.67%
0.94%
자본화:
|
볼륨(24시간):